Profile picture

Professor Charlotte Manisty

University College London, London (United Kingdom of Great Britain & Northern Ireland)
Membership: FESC Member
Follow
Biography
Charlotte Manisty is Associate Professor of at University College London and set up and leads the largest cardio-oncology service in the UK at Barts Hospital, London. She and also has expertise in heart failure and cardiac imaging, and leads a research group whose current research interests include optimising imaging using computational techniques for identifying patients at risk of developing cardiotoxicity, and understanding the vascular toxicity of chemotherapeutic agents. She chairs the SCMR Cardio-oncology group, and is Research Lead for British Cardio-oncology Society. She is regularly invited to speak both Nationally and at International conferences on Cardio-oncology and Imaging, and chairs the UK Multi-Societal Working Group on MRI in patients with cardiac devices. She receives funding for her work from BHF and NHLI, and has published over 100 papers and book chapters, alongside supervising PhD students and teaching.
Logo ESC

Contributor content

From paper to startup
Session
From paper to startup
13 November 2026
Can AI see what the eye can not?
Session
Can AI see what the eye can not?
12 November 2026
Beyond the algorithm: why AI still fails at the point of care delivery in cardiovascular care
Session
Beyond the algorithm: why AI still fails at the point of care delivery in cardiovascular care
12 November 2026
Advanced cardiovascular magnetic resonance phenotyping in heart muscle diseases
Session
Advanced cardiovascular magnetic resonance phenotyping in heart muscle diseases
31 August 2026
Great Debate: artificial intelligence vs. humans in cardiac imaging
Session
Great Debate: artificial intelligence vs. humans in cardiac imaging
30 August 2026
Prevention and early detection of cardiovascular toxicity in patients with cancer and cancer survivors
Session
Prevention and early detection of cardiovascular toxicity in patients with cancer and cancer survivors
29 August 2026
Intersecting inflammation: cardiovascular disease across systemic condition
Session
Intersecting inflammation: cardiovascular disease across systemic condition
29 August 2026
Clinical science in cardio-oncology
Session
Clinical science in cardio-oncology
20 June 2026
From fibrosis to function: the expanding role of CMR in non-ischaemic DCM
Session
From fibrosis to function: the expanding role of CMR in non-ischaemic DCM
13 December 2025
Cardiac effects of chemotherapy
Session
Cardiac effects of chemotherapy
13 December 2025